{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:42:03Z","timestamp":1774316523218,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.ajo.2006.02.044","type":"journal-article","created":{"date-parts":[[2006,8,17]],"date-time":"2006-08-17T12:43:19Z","timestamp":1155818599000},"page":"310-315.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Ischemic Necrosis and Atrophy of the Optic Nerve After Periocular Carboplatin Injection for Intraocular Retinoblastoma"],"prefix":"10.1016","volume":"142","author":[{"given":"Ingo","family":"Schmack","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Baker","family":"Hubbard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin J.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Thomas M.","family":"Aaberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans E.","family":"Grossniklaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2006.02.044_bib1","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archopht.1990.01070030134045","article-title":"The incidence of retinoblastoma in the United States","volume":"108","author":"Tamboli","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.02.044_bib2","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ophtha.2003.10.023","article-title":"Incidence of retinoblastoma from 1958 to 1998 in Northern Europe","volume":"111","author":"Seregard","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2006.02.044_bib3","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1200\/JCO.2005.00.554","article-title":"Childhood cancer survival trends in Europe","volume":"23","author":"Gatta","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajo.2006.02.044_bib4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00055735-200210000-00007","article-title":"Current treatment of retinoblastoma","volume":"13","author":"DePotter","year":"2002","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ajo.2006.02.044_bib5","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/00006982-200412000-00002","article-title":"Update on retinoblastoma","volume":"24","author":"Abramson","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2006.02.044_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ajo.2004.04.032","article-title":"Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors","volume":"138","author":"Shields","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2006.02.044_bib7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/222385a0","article-title":"Platinum compounds","volume":"222","author":"Rosenberg","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.ajo.2006.02.044_bib8","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/S0161-6420(99)90406-2","article-title":"A phase I\/II study of subconjunctival carboplatin for intraocular retinoblastoma","volume":"106","author":"Abramson","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2006.02.044_bib9","first-page":"1892","article-title":"Local carboplatin therapy in transgenic murine retinoblastoma","volume":"37","author":"Harbour","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2006.02.044_bib10","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/archopht.116.9.1209","article-title":"Intraocular concentrations of chemotherapeutic agents after systemic or local administration","volume":"116","author":"Mendelsohn","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.02.044_bib11","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/archopht.118.11.1549","article-title":"Subconjunctival carboplatin in retinoblastoma. Impact of tumor burden and dose schedule","volume":"118","author":"Hayden","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.02.044_bib12","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1167\/iovs.04-0228","article-title":"Pharmacokinetics of systemic versus focal carboplatin chemotherapy in the rabbit eye","volume":"45","author":"Hayden","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2006.02.044_bib13","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00006982-200410000-00015","article-title":"Retinal function after subconjunctival injection of carboplatin in fibrin sealant","volume":"24","author":"Pardue","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2006.02.044_bib14","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ophtha.2004.11.060","article-title":"Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma","volume":"112","author":"Van Quill","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2006.02.044_bib15","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/archopht.121.8.1120","article-title":"Ocular motility changes after subtenon carboplatin chemotherapy for retinoblastoma","volume":"121","author":"Mulvihill","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.02.044_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1200\/JCO.2000.18.1.12","article-title":"Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma","volume":"18","author":"Friedman","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajo.2006.02.044_bib17","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/S0161-6420(03)00669-9","article-title":"New retinoblastoma tumor formation in children initially treated with systemic carboplatin","volume":"110","author":"Lee","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2006.02.044_bib18","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/archopht.120.4.460","article-title":"Factors predictive of recurrence of retinal tumor, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma","volume":"120","author":"Shields","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.02.044_bib19","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1016\/S0959-8049(97)10019-3","article-title":"High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a hematopoietic stem cell rescue in patients with high-risk retinoblastoma","volume":"33","author":"Namoumi","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajo.2006.02.044_bib20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2165\/00002018-199513040-00003","article-title":"Comparative adverse effect profiles of platinum drugs","volume":"13","author":"McKeage","year":"1995","journal-title":"Drug Safety"},{"key":"10.1016\/j.ajo.2006.02.044_bib21","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1021\/cr00081a013","article-title":"Structural aspects of platinum anti-cancer drug interactions with DNA","volume":"87","author":"Sherman","year":"1987","journal-title":"Chem Rev"},{"key":"10.1016\/j.ajo.2006.02.044_bib22","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1001\/archopht.1977.04450100161023","article-title":"Methyl alcohol poisoning IV. Alterations of the morphological findings of the retina and optic nerve","volume":"95","author":"Baumbach","year":"1977","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.02.044_bib23","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00417-002-0573-9","article-title":"Severe ocular and orbital toxicity after intracarotid injection of carboplatin for recurrent glioblastomas","volume":"240","author":"Watanabe","year":"2002","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2006.02.044_bib24","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1212\/01.WNL.0000147263.89255.B8","article-title":"Progressive outer retinal necrosis presenting with isolated optic neuropathy","volume":"63","author":"Nakamoto","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ajo.2006.02.044_bib25","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.ijrobp.2004.12.009","article-title":"Does altered fractionation influence the risk of radiation-induced optic neuropathy?","volume":"62","author":"Bhandare","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ajo.2006.02.044_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/030098587601300501","article-title":"Degenerative myelopathy in three strains of aging rats","volume":"13","author":"Burek","year":"1976","journal-title":"Vet Pathol"},{"key":"10.1016\/j.ajo.2006.02.044_bib27","first-page":"181","article-title":"Ultrastructure of the extracellular matrix of bovine dura mater, optic nerve sheath and sclera","volume":"181","author":"Raspanti","year":"1992","journal-title":"J Anat"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939406003394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939406003394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:52:15Z","timestamp":1757595135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939406003394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0002939406003394"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2006.02.044","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ischemic Necrosis and Atrophy of the Optic Nerve After Periocular Carboplatin Injection for Intraocular Retinoblastoma","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2006.02.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}